CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-11 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise | +19,830 | 57,744 | ||
| 2026-05-11 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −11,004 | $79.96 | $880K | 46,740 |
| 2026-05-11 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Performance Rights | −19,830 | 0 | ||
| 2026-05-08 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −1,661 | $82.76 | $137K | 37,914 |
| 2026-05-07 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −1,373 | $83.20 | $114K | 39,575 |
| 2026-05-05 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise | +13,000 | $59.26 | $770K | 52,079 |
| 2026-05-05 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −11,131 | $82.91 | $923K | 40,948 |
| 2026-05-05 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) | −13,000 | 0 | ||
| 2026-05-03 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −620 | $83.98 | $52K | 39,079 |
| 2026-04-09 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +13,000 | $59.26 | $770K | 52,699 |
| 2026-04-09 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −4,676 | $80.50 | $376K | 48,023 |
| 2026-04-09 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −8,324 | $79.79 | $664K | 39,699 |
| 2026-04-09 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −13,000 | 13,000 | ||
| 2026-03-11 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +13,000 | $59.26 | $770K | 52,699 |
| 2026-03-11 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −5,099 | $84.46 | $431K | 47,600 |
| 2026-03-11 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −7,901 | $85.21 | $673K | 39,699 |
| 2026-03-11 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −13,000 | 26,000 | ||
| 2026-02-16 | Ullem Scott B. CVP, Chief Financial Officer | Shares withheld for taxes | −199 | $75.87 | $15K | 39,699 |
| 2025-12-09 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +7,700 | $59.26 | $456K | 47,598 |
| 2025-12-09 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −7,700 | $84.47 | $650K | 39,898 |
Page 1 of 4 · 69 trades